Independent Quality
Assurance System
Medleader has established an independent quality assurance system for the four major business platforms of pharmaceutical research, drug safety evaluation research, clinical medicine, and biotechnology. Covering the company's various business areas and projects, from complete quality system documents, to comprehensive personnel training, and strict quality supervision and inspection. At present, the quality assurance system can not only independently perform quality management on the four major business platforms and related content, but also operate jointly to meet the needs of different projects of customers. Through comprehensive internal quality control and quality assurance, the quality of the entire process of project operation is controllable and the compliance of project operation is ensured.
美莱德药物安全评价研究中心拥有独立的质量保证部门,建立了系统化、标准化的QA检查规范与记录体系, QA对试验方案、试验设施、试验过程、人员资质与能力等各个试验与管理环节进行检查,确保试验研究的规范性。
美莱德药物安全评价研究中心秉承客观、严谨、求实的质量理念,遵照NMPA、OECD或FDA的GLP规范、试验方案及SOPs要求独立开展质量监督, 确保安全性试验的GLP依从性,保障试验数据的真实性、完整性和可靠性。
The Drug Safety Evaluation and Research Center has an independent quality assurance department, and has established a systematic and standardized QA inspection specification and recording system. QA conducts various tests and management links such as test schemes, test facilities, test processes, personnel qualifications and capabilities, etc. Carry out inspections to ensure the standardization of experimental research.
Purpose
The Drug Safety Evaluation and Research Center adheres to the objective, rigorous, and realistic quality concept, and independently carries out quality supervision in accordance with the GLP specifications, test protocols and SOPs requirements of NMPA, OECD or FDA to ensure GLP compliance for safety tests and guarantee test data The authenticity, completeness and reliability of the product.
美莱德临床医学平台基于NMPA、ICH临床试验相关法律、法规及指导原则(GCP)创建质量管理体系, 提供全方位、高覆盖率的质控及稽查服务。通过了ISO9001:2015质量认证,建立了50余项标准操作规程、200多个原始表格, 囊括了方案质量、人员质量、研究中心质量、数据及记录质量、质量保证、临床试验供应质量、药物警戒质量、过程管理及持续提高; 多次通过客户及第三方稽查,NMPA国家局现场核查,保证实验过程中无重大质量问题。
美莱德生物分析技术平台依据NMPA、中国合格评定国家认可委员会(CNAS)、FDA颁布的相关法规、准则和指南建立了完整的质量管理体系, 并严格执行和持续改进。取得了CNAS实验室认可证书,并多次通过国家局核查、第三方稽查和客户审计。
生物分析技术平台具有独立的质量保证部,对实验人员、设施设备、计算机系统、试剂耗材、实验方案、分析方法、实验记录、分析报告以及质量控制等进行稽查。 确保运行项目法规依从性,保障试验数据的真实性、完整性和可靠性。